Real-time enrollment status for this chronic hepatitis b clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 3:22 PM UTC
| NCT Number | NCT06963710 |
| Recruiting Status | Recruiting |
| Condition | Chronic Hepatitis B |
| Phase | PHASE2 |
| Target Enrollment | 200 participants |
| Active Locations | 18 sites in the US |
| Sponsor | Aligos Therapeutics |
| Last Updated on CT.gov | May 1, 2026 (May 1, 2026) |
As of July 18, 2026: Clinical trial NCT06963710 is currently recruiting participants. This phase2 study for chronic hepatitis b is actively seeking new participants at 18 locations across the United States. The study is sponsored by Aligos Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06963710 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 18 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06963710 was last updated May 1, 2026 (May 1, 2026). HelloStudys verifies this status automatically.